FIELD: medicine.
SUBSTANCE: present invention relates to treating multiple sclerosis. Disclosed is use of an R-enantiomer of tarenflurbil (R-flurbiprofen) for use in treating multiple sclerosis.
EFFECT: reduced demyelination of shells around axons.
7 cl, 10 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| TREATMENT OF DEMYELINATING DISEASES | 2019 |
|
RU2805061C2 |
| ORGANIC COMPOUNDS | 2003 |
|
RU2478378C2 |
| METHOD FOR TREATING MULTIPLE SCLEROSIS USING LSD1 INHIBITOR | 2017 |
|
RU2768120C2 |
| APPLICATION OF S1P RECEPTOR AGONIST AND METHOD OF TREATMENT, ALLEVIATION OR RETARDATION OF OPTIC NEURITIS OR DEMYELINATING DISEASES PROGRESSION | 2003 |
|
RU2391094C2 |
| METHOD OF TREATING MULTIPLE SCLEROSIS | 2010 |
|
RU2539034C2 |
| COMPOSITION AND METHOD OF AUTOIMMUNE DISEASES TREATMENT | 2012 |
|
RU2621129C2 |
| GENE-CELL VESICULAR THERAPEUTIC DRUG AND METHOD FOR MULTIPLE SCLEROSIS THERAPY BY TRANSPLANTATION OF A GENE-CELL VESICULAR THERAPEUTIC DRUG | 2021 |
|
RU2762855C1 |
| PEPTIDE FROM THE COMPOSITION OF THE IMMUNOGLOBULIN HUMAN HEAVY CHAIN, SUITABLE FOR TREATMENT OF MULTIPLE SCLEROSIS | 2016 |
|
RU2646817C1 |
| COMPOSITIONS FOR TREATMENT OF DISSEMINATED SCLEROSIS | 2008 |
|
RU2492234C2 |
| LIPOSOMES CONTAINING OLIGOPEPTIDE FRAGMENTS OF MYELIN BASIC PROTEIN, PHARMACEUTICAL COMPOSITION AND METHOD FOR MULTIPLE SCLEROSIS TREATMENT | 2013 |
|
RU2639497C2 |
